Gelonghui March 12 | China Antibody-B (03681.HK) announced that a board meeting will be held on March 25, 2024 (Monday) to consider and approve the Group's annual results and announcements for the year ended December 31, 2023, and to deal with other matters.
中国抗体-B(03681.HK)拟3月25日举行董事会会议考虑及批准全年业绩
China Antibody-B (03681.HK) plans to hold a board meeting on March 25 to consider and approve annual results
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.